Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of STA-2 in Patients With Chronic Stable Angina

NCT01484912 is registered in ClinicalTrials.gov with Sinphar Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01484912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01484912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of STA-2 in Patients With Chronic Stable Angina
Lead sponsor
Sinphar Pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
June 30, 2008
Enrollment
79 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable angina